**Core Concept**
Prostanoids are a class of eicosanoid lipid compounds that play a crucial role in various physiological and pathological processes. They are produced from arachidonic acid and serve as potent mediators of inflammation, platelet aggregation, and smooth muscle contraction.

**Why the Correct Answer is Right**
Prostanoids, particularly prostaglandins (PGs) and prostacyclin (PGI2), are not typically used for the closure of patent ductus arteriosus (PDA). The closure of PDA is usually achieved through pharmacological means using nonsteroidal anti-inflammatory drugs (NSAIDs) like indomethacin, which inhibit the production of prostaglandins, thereby promoting ductal closure. Prostanoids themselves would actually exacerbate the condition by promoting vasodilation and inhibiting platelet aggregation, making it unsuitable for PDA closure.

**Why Each Wrong Option is Incorrect**
**Option A:** Prostaglandins, particularly PGF2α, can be used in the treatment of glaucoma to reduce intraocular pressure by increasing uveoscleral outflow.
**Option B:** Prostacyclin (PGI2) is a potent inhibitor of platelet aggregation and can be used to treat platelet coagulation disorders like thrombocytopenia or thrombocytopathia.
**Option C:** Prostaglandin E2 (PGE2) can be used to stimulate gastric mucosal secretion and protect the gastric mucosa, making it useful in the treatment of gastric ulcers.

**Clinical Pearl / High-Yield Fact**
It is essential to remember that prostanoids have different effects on various tissues and organs, and their use should be tailored to the specific condition being treated. This requires a thorough understanding of their mechanisms of action and potential side effects.

✓ Correct Answer: D. Closure of PDA.